Paper
0
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
Authors
James Kochenderfer,Mark Dudley
Robert Carpenter,Sadik Kassim,Jeremy Rose,William Telford,Frances Hakim,David Halverson,Daniel Fowler,Nancy Hardy,Anthony Mato,Dennis Hickstein,Juan Gea‐Banacloche,Steven Pavletic,Claude Sportès,Irina Marić,Steven Feldman,Brenna Hansen,Jennifer Wilder,Bazetta Blacklock-Schuver,Bipulendu Jena,Michael Bishop,Ronald Gress
+21 authors
,Steven RosenbergJournal
Published
Sep 21, 2013
Show more
Save
Tip0
TipSave
Abstract
Key Points Donor-derived anti-CD19-CAR T cells cause regressions of refractory malignancies after allogeneic transplantation.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.